TY - JOUR
T1 - Dried Blood Matrix as a New Material for the Detection of DNA Viruses
AU - Lim, Jongwon
AU - Hwang, Joanne
AU - Min, Hyegi
AU - Wester, Matthew
AU - Kim, Chansong
AU - Valera, Enrique
AU - Kong, Hyun Joon
AU - Bashir, Rashid
N1 - R.B. and E.V. acknowledge support from the Jump ARCHES (Applied Research through Community Health through Engineering and Simulation) endowment through the Health Care Engineering Systems Center at UIUC and OSF. This work was supported, in part, by the Dynamic Research Enterprise for Multidisciplinary Engineering Sciences (DREMES) Center funded by the Zhejiang University of Illinois ZJUI Joint Institute. The authors thank the staff at the Holonyak Micro and Nanotechnology Laboratory at UIUC for facilitating the research and the funding from the University of Illinois.
PY - 2024/11/22
Y1 - 2024/11/22
N2 - The gold standard for diagnosing viruses such as the Hepatitis B Virus has remained largely unchanged, relying on conventional methods involving extraction, purification, and polymerase chain reaction (PCR). This approach is hindered by limited availability, as it is time-consuming and requires highly trained personnel. Moreover, it suffers from low recovery rates of the nucleic acid molecules for samples with low copy numbers. To address the challenges of complex instrumentation and low recovery rate of DNA, a drying process coupled with thermal treatment of whole blood is employed, resulting in the creation of a dried blood matrix characterized by a porous structure with a high surface-to-volume ratio where it also inactivates the amplification inhibitors present in whole blood. Drawing on insights from Brunauer–Emmett–Teller (BET)- Barrett–Joyner–Halenda (BJH) analysis, scanning electron microscopy (SEM), and fluorescence recovery after photobleaching (FRAP), detection assay is devised for HBV, as a demonstration, from whole blood with high recovery of DNA and simplified instrumentation achieving a limit of detection (LOD) of 10 IU mL−1. This assay can be completed in <1.5 h using a simple heater, can be applied to other DNA viruses, and is expected to be suitable for point-of-care, especially in low-resource settings.
AB - The gold standard for diagnosing viruses such as the Hepatitis B Virus has remained largely unchanged, relying on conventional methods involving extraction, purification, and polymerase chain reaction (PCR). This approach is hindered by limited availability, as it is time-consuming and requires highly trained personnel. Moreover, it suffers from low recovery rates of the nucleic acid molecules for samples with low copy numbers. To address the challenges of complex instrumentation and low recovery rate of DNA, a drying process coupled with thermal treatment of whole blood is employed, resulting in the creation of a dried blood matrix characterized by a porous structure with a high surface-to-volume ratio where it also inactivates the amplification inhibitors present in whole blood. Drawing on insights from Brunauer–Emmett–Teller (BET)- Barrett–Joyner–Halenda (BJH) analysis, scanning electron microscopy (SEM), and fluorescence recovery after photobleaching (FRAP), detection assay is devised for HBV, as a demonstration, from whole blood with high recovery of DNA and simplified instrumentation achieving a limit of detection (LOD) of 10 IU mL−1. This assay can be completed in <1.5 h using a simple heater, can be applied to other DNA viruses, and is expected to be suitable for point-of-care, especially in low-resource settings.
KW - DNA amplifications
KW - direct detection from whole blood
KW - dried blood matrix
KW - hepatitis B virus
KW - material characterization
KW - point-of-care diagnostics
KW - purification-free amplifications
UR - http://www.scopus.com/inward/record.url?scp=85199969819&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85199969819&partnerID=8YFLogxK
U2 - 10.1002/adhm.202402506
DO - 10.1002/adhm.202402506
M3 - Article
C2 - 39075818
AN - SCOPUS:85199969819
SN - 2192-2640
VL - 13
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
IS - 29
M1 - 2402506
ER -